You are here: Industry Insights > SARS-CoV-2

News List

SARS-CoV-2 IgG Antibody Test Receives FDA Emergency Use Authorization americanpharmaceuticalreview
July 08, 2020
Beckman Coulter announced its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA).
Newer variant of COVID-19-causing virus dominates global infections worldpharmanews
July 03, 2020
Research out today in the journal Cell shows that a specific change in the SARS-CoV-2 coronavirus virus genome, previously associated with increased viral transmission and the spread of COVID-19, is more infectious in cell culture.
IgNova Files Patent Application on Antibody Against COVID-19 americanpharmaceuticalreview
July 03, 2020
IgNova has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY).
Researchers identify multiple molecules that shut down SARS-Cov-2 polymerase reaction worldpharmanews
July 02, 2020
SARS-CoV-2, the coronavirus causing the global COVID-19 pandemic, uses a protein called polymerase to replicate its genome inside infected human cells.
FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines worldpharmanews
July 01, 2020
The U.S. Food and Drug Administration took important action to help facilitate the timely development of safe and effective vaccines to prevent COVID-19 by providing guidance with recommendations for those developing COVID-19 vaccines ...
Whole-town study reveals more than 40% of COVID-19 infections had no symptoms worldpharmanews
July 01, 2020
A study of COVID-19 in the quarantined Italian town of Vò, where most of the population was tested, reveals the importance of asymptomatic cases.
Researchers identify drugs that may block cell to cell transmission of coronavirus expresspharma
July 01, 2020
The scientists analysed all host and viral proteins that showed changes in an enzymatic process called phosphorylation after SARS-CoV-2 infection.
Existing drugs can prevent SARS-CoV-2 from hijacking cells worldpharmanews
June 30, 2020
An international team of researchers has analysed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells.
Lilly begins world's first study of a potential COVID-19 antibody treatment in humans worldpharmanews
June 29, 2020
Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19.
Study identifies immune cells involved in protection against COVID-19 expresspharma
June 29, 2020
A study, published in the journal Science Immunology, assessed T cells from 10 COVID-19 patients under intensive care treatment.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page